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Abstract: The process of molting, known alternatively as ecdysis, is a feature integral in the life cycles of species across the
arthropod phylum. Regulation occurs as a function of the interaction of ecdysteroid hormones with the arthropod nuclear
ecdysone receptor—a process preceding the triggering of a series of downstream events constituting an endocrine signaling
pathway highly conserved throughout environmentally prevalent insect, crustacean, and myriapod organisms. Inappropriate
ecdysone receptor binding and activation forms the essential molecular initiating event within possible adverse outcome
pathways relating abnormal molting to mortality in arthropods. Definition of the characteristics of chemicals liable to stim-
ulate such activity has the potential to be of great utility in mitigation of hazards posed toward vulnerable species. Thus the
aim of the present study was to develop a series of rule‐sets, derived from the key structural and physicochemical features
associated with identified ecdysone receptor ligands, enabling construction of Konstanz Information Miner (KNIME) work-
flows permitting the flagging of compounds predisposed to binding at the site. Data describing the activities of 555 distinct
chemicals were recovered from a variety of assays across 10 insect species, allowing for formulation of KNIME screens for
potential binding activity at the molecular initiating event and adverse outcome level of biological organization. Environ
Toxicol Chem 2020;39:1438–1450. © 2020 The Authors. Environmental Toxicology and Chemistry published by Wiley
Periodicals LLC on behalf of SETAC.
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INTRODUCTION
Endocrine systems are present in the great majority of an-
imal phyla, playing integral roles in the mediation of essential
developmental, reproductive, neurological, and immune func-
tions. Although great diversity in form and complexity is found
across species, common defining features may be discerned,
including the secretion of hormones by glands into the circu-
latory system and the action of these signaling molecules at
distant, dedicated receptor sites. Because of the physiological
importance of endocrine pathways, disruption of function can
have substantial consequence to organisms (Tyler et al. 1998).
Exogenous chemicals that interfere with endocrine physiology,
and induce adverse effects, are defined as endocrine disruptors
(Colborn et al. 1993). Typically, chemical stressors modulate
pathways through agonism or antagonism by acting on re-
ceptors. Identification of endocrine‐disrupting substances re-
mains an ongoing enterprise, with continued expansion of the
number of associated compounds (which currently exceed
8000) as further toxicological data are gathered (Bergman
et al. 2013; Birnbaum 2013).
A report published in 2002 through the International Program
on Chemical Safety (IPCS) sought to assess the existing state of
knowledge of endocrine disruption. Considering a varied array of
species, the IPCS study highlighted deficits in the availability
of appropriate supporting evidence concerning the status
of specific endocrine disruptors (Darmstra et al. 2002). Our un-
derstanding has since continued to develop, strengthened by an
increased focus on mechanistic aspects underpinning pathway
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activation (Diamanti‐Kandarakis et al. 2009; Kortenkamp et al.
2011; Skakkebaek et al. 2011). An area of investigation that re-
quires greater definition is endocrine disruption across in-
vertebrate phyla. Within the arthropod phylum, which consists of
a range of environmentally ubiquitous species from classes in-
cluding Insecta, Crustacea, and Arachnida, a thorough under-
standing of the endocrine‐disrupting potential relative to
prevalent pesticide compounds is lacking. (Colborn et al. 1993;
Stanley and Preetha 2016).
The adverse outcome pathway (AOP) framework can be
useful in linking a given stressor to an adverse outcome
through consideration of molecular initiating events and inter-
mediate key events. Ecdysteroid signaling is of importance to
arthropod growth and development and is considered an en-
docrine pathway integral to exoskeleton shedding in molting
and metamorphosis (Yamanaka et al. 2013). Interaction of
ecdysteroid hormones, such as ecdysone (Figure 1A) and
20‐hydroxyecdysone (Figure 1B), with the ecdysone receptor
(EcR) constitutes the main molecular initiating event in any AOP
for this effect. The EcR exists as a complex composed of
2 subunits, these being the EcR and ultraspiracle proteins
(Gunamalai et al. 2004; Hill et al. 2013; Sumiya et al. 2014). In
common with other nuclear receptors, the EcR possesses a
ligand‐binding domain within which is incorporated a hydro-
phobic cleft formed from an arrangement of 12 α‐helices. Its
dimensions are such that it may accommodate binders dis-
playing structural deviation from the classical steroidal tem-
plate (Billas et al. 2003; Evenseth et al. 2019).
The AOPs associating perturbation of ecdysone signaling in
arthropods with impaired molting culminating in death have
been described (for a general outline, see Figure 2; Song
et al. 2017b; Song and Tollefsen 2018). A variety of endoge-
nous and xenobiotic substances are known to act through the
EcR, but definitions of the structural and physicochemical
characteristics required for binding remain incomplete. Mod-
eling of receptor binding sites has provided insight into inter-
actions underlying docking affinity—although this knowledge
has not been applied in predictive toxicology (Kasuya
et al. 2003; Zotti et al. 2012; Evenseth et al. 2019). It is clearly
neither practical nor desirable to assess indiscriminately the
binding activity of vast chemical libraries through existing in
vivo or in vitro means, and hence a rationale is provided for the
development of in silico techniques allowing strategies for
identification of compounds likely to act at the site.
The aim of the present study was to construct a computa-
tional screen for the ability of compounds to bind to the EcR.
Literature sources were examined for data concerning the
identities of chemicals verified experimentally as acting at the
site. Although the availability of these data necessarily led us to
focus on insect species, it is intended that scope for applic-
ability within crustacean, myriapod, and arachnid classes be
demonstrated through means of sequence homology com-
parison. Both structural features and computed phys-
icochemical characteristics were analyzed with the aim of
developing sets of structural alerts and physicochemical
property ranges enabling identification of molecules displaying
high affinity for the EcR. In line with AOP methodology, a dis-
tinction was made between compounds shown to induce
downstream effects characteristic of pathway activation (the
adverse outcome) and compounds definitively acting at the
receptor (the molecular initiating event). Following compila-
tion, these sequences were implemented into freely available
workflows for use in the open‐access data analysis software
Konstanz Information Miner (KNIME).
MATERIALS AND METHODS
Collection and consideration of data
Data concerning the identity and activity of potential EcR
agonists were retrieved through both a literature search and
the open‐access ChEMBL database (Gaulton et al. 2011;
European Bioinformatics Institute 2020). In vivo and in vitro
experimental outcomes were considered suitable for inclusion.
For the purposes of model building, assay systems were clas-
sified according to the biological level of organization
(adopting the AOP, i.e., the molecular initiating event–key
event–adverse outcome framework) at which the impact of EcR
agonism on the test organism was characterized. Those sys-
tems describing effects on life‐cycle progression of intact or-
ganisms (EcR agonist–associated molting abnormality) were
deemed representative of the adverse outcome, whereas those
conversely relating either to direct receptor binding (EcR
activation) or to localized influence on isolated tissues (tissue
phenotype or biochemical alteration) were adopted to describe
the molecular initiating event. Two distinct models were
FIGURE 1: Chemical structures of the most prevalent ecdysteroids,
ecdysone (A) and 20‐hydroxyecdysone (B).
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constructed from these data, one corresponding solely to the
molecular initiating event level, the other solely to the adverse
outcome. For a summary of relevant information concerning
these assay systems, see Table 1.
Compounds exhibiting assay activity above defined thresh-
olds were deemed “active”—indicating their greater likelihood
of holding capacity to induce effects specifically mediated
through EcR binding. Drawing on the distinction adopted by
Dinan, these included all compounds possessing median effect
concentration values less than 10–4 M (Dinan 2003). In studies
employing alternative designs, such as that of Smith et al. (2003),
an increase in activity relative to vehicle control was regarded as
sufficient. Those falling outside these boundaries were, con-
versely, classified as “inactive.” It was judged that affinity was
low enough that they might induce adverse effects through al-
ternative pathways at the concentrations required for ecdysone
binding response, and hence may be considered as nonspecific
binders to the receptor.
Under the “Targets” heading, a search for “ecdysone re-
ceptor” was performed in the ChEMBL_25 database (European
Bioinformatics Institute 2020). Data describing activity at “single
protein” targets were considered appropriate for inclusion.
Assessment of interspecies variability in
ligand‐binding domain structure
Homology in amino acid sequence corresponding to the
ligand‐binding domain of the EcR was determined between
relevant species through use of the US Environmental
Protection Agency (USEPA) Sequence Alignment to Predict
Across Species Susceptibility (SeqAPASS) tool (Ver 4.0;
FIGURE 2: Schematic representation of the putative adverse outcome pathway (AOP) through which ecdysone receptor activation increases
molting disruption and mortality in arthropods.
TABLE 1: Summary of study details and data distribution showing adverse outcome–level and molecular initiating event–level effectsa
Species Assay system Tissue/life stage Outcome
Entries
SourceAct. In.
Adverse outcome Bombyx mori Whole organism Larval phase Molting abnormality 4 — Rajathi et al. 2010
Calliphora erythrocephala Whole organism Prepupal phase Molting abnormality 32 29 Dinan 2003
Chilo suppressalis Whole organism Larval phase Molting abnormality 3 — Dinan 2003





3T3 cell line EcR activation 34 2 Smith et al. 2003
3 — Soin et al. 2010b
Bombyx mori Arthropod cell Bm5 cell line EcR activation 32 1 Soin et al. 2010a
70 12 Soin et al. 2010b
Transfected
mammalian cell
HEK‐293 cell line EcR activation 19 — Tice et al. 2003b
34 5 Tice et al. 2003a
Bovicola ovis Recombinant protein Baculovirus vector EcR activation 103 15 Birru et al. 2010
Calliphora erythrocephala Isolated tissue Imaginal disc Tissue form alteration 5 — Dinan 2003
Chilo suppressalis Isolated tissue Integument Tissue form alteration 5 — Dinan 2003
Chironomus tentans Arthropod cell Epithelial cell line EcR activation 3 — Dinan 2003
Choristoneura fumiferana Transfected
mammalian cell
HEK‐293 cell line EcR activation 18 — Tice et al. 2003b
Drosophila melanogaster Arthropod cell BII cell line EcR activation 145 10 Dinan 2003
C18+ cell line EcR activation 4 — Dinan 2003
Kc cell line EcR activation 13 — Dinan 2003
15 4 Harada et al. 2009
44 — Soin et al. 2010b
Isolated tissue Imaginal disc Tissue form alteration 5 1 Dinan 2003
Lucilia cuprina Recombinant protein Baculovirus vector EcR activation 21 3 Birru et al. 2010
Spodoptera littoralis Arthropod cell SL2 cell line EcR activation 36 1 Soin et al. 2010a
aThe column “Entries” describes the quantity of individual compounds, both active (act.) and inactive (in.) present in each.
EcR= ecdysone receptor.
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LaLone et al. 2016). At evaluation level 1, sequences relating
to the EcR in its entirety were sought (a list of the corre-
sponding National Center for Biotechnology Information
accession numbers is given in the Supplemental Data,
Table S1). Once these sequences had been recovered,
evaluation level 2 analysis was performed focused exclusively
on the ligand‐binding domain (NR_LBD_EcR). A comparison
of level 2 homology determined the extent of variability in
interspecies ligand receptibility, with values exceeding the
susceptibility cut‐offs defined by SeqAPASS considered
representative of acceptable similarity (LaLone et al. 2016).
Identification and construction of key structural
features and alerts
The molecular structure of each compound in the compiled
binder list was visualized in the freely available Molecular Net-
works ChemoTyper software (Ver 1.0; Yang et al. 2015). Exami-
nation of the structures in the active set permitted the
identification of key characteristics associated with receptor af-
finity. This process was informed through employment of
chemical knowledge, combined with information gathered from
existing literature sources. Features and alerts identified as being
important for binding were coded into SimplifiedMolecular Input
Line Entry System (SMILES) arbitrary target specification
(SMARTS) strings, constructed so that they might enable re-
tention of key spatial features, while simultaneously permitting
degrees of deviation from known binder structure and excluding,
as far as possible, those associated with inactivity and poor af-
finity in a procedure analogous to those previously reported
(Steinmetz et al. 2015; Mellor et al. 2016). The strings compiled
were subsequently applied in KNIME through use of the RDKit
Substructure Filter node (Ver 2019.03.1; Landrum 2016). A dis-
tinction was drawn between those compounds possessing ster-
oidal (ecdysteroids and derivatives) and nonsteroidal structure,
with unique rule‐sets in each workflow constructed for each.
Calculation of molecular physicochemical
descriptors
Physicochemical properties for each binder were calculated in
KNIME (Ver 3.5.3; Berthold et al. 2008) courtesy of the Chemistry
Development Kit Molecular Properties node (Ver 1.5.12; Steinbeck
et al. 2003). To facilitate processing, structures of compounds
were encoded as SMILES strings (Anderson et al. 1987).
Integration of structural and physicochemical
parameters in KNIME workflow
We incorporated the structural alert and physicochemical
property–derived inclusion and exclusion criteria ascertained
through methods described in the previous sections, Identi-
fication and construction of key structural features and alerts and
Calculation of molecular physicochemical descriptors. Then
workflows enabling prediction of potential EcR binding capacity
across test compounds were constructed using the KNIME
software. In all, 2 distinct flows were constructed—one confined
to compounds possessing molecular initiating event–level activity
data and the other to compounds causing effects at the adverse
outcome level. A sequence of filters, constituting a rule‐set, was
implemented through employment of appropriate nodes. Com-
pounds were entered into the workflow as SMILES, and mole-
cules matching SMARTS‐encoded structural fragment markers (as
well as those falling within the boundaries of the physicochemical
property ranges) were classed as prospective EcR agonists. Those
failing either count were deemed inactive.
RESULTS
Collection and profiling of data
Data availability and coverage. From sources detailed
previously in the Collection and consideration of data section, a
collection of 555 unique chemical entities with data relating
activity either at, or through, the EcR was recovered. These
data were present exclusively in insects (across a total of
10 species). Of these compounds, 470 were deemed active
agonists (detailed in the Supplemental Data, Table S2): ec-
dysteroids and their derivatives accounted for 196 chemicals
and nonsteroidal binders for the remaining 274. Classified ac-
cording to experimental characterization, 434 compounds were
identified as having molecular initiating event–level EcR
binding potential, with 59 displaying adverse outcome effects.
(A minority of 23 possessed data attesting to both character-
istics.) The activities of 160 steroids were characterized by
molecular initiating event–relevant assays, alongside all 274 of
the nonsteroidal cohort. Adverse outcome–level data were
present across 55 steroidal and 4 nonsteroidal binders.
Conversely, 85 compounds were categorized as inactive,
48 steroidal and 37 nonsteroidal (listed in the Supplemental
Data, Table S3). Each of the latter was characterized solely at
the molecular initiating event level. Of the steroidal set,
34 possessed only adverse outcome–applicable data and
14 had data only at the molecular initiating event level. No
adverse outcome–level nonsteroidal inactives were identified.
Assessment of interspecies variability in ligand‐binding
domain structure. With data drawn from 10 distinct insect
species, it was necessary to discern the extent to which the se-
quence homology of the relevant EcR binding domains remained
conserved. It was furthermore desirable to assess how this sim-
ilarity might extend to arthropods outside the hexapod class, in-
cluding arachnids, crustaceans, and myriapods. Through use of
the SeqAPASS tool (as described previously in Assessment of
interspecies variability in ligand‐binding domain structure), com-
parisons between the amino acid sequences present in the
ligand‐binding domains of the respective EcRs were performed.
Data were available for 8 of 10 insect species, the exceptions
being Bovicola ovis andMusca domestica. A predicted sequence
present for M. domestica was adopted, whereas B. ovis was by
necessity excluded. Representative arachnid (Agelena silvatica),
crustacean (Callinectes sapidus), and myriapod (Lithobius
peregrinus) species were included in addition.
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Table 2 shows that the general extent of homology in in-
sects is high, far exceeding the susceptibility cut‐off points
determined using SeqAPASS (which had 16–27% homology;
Supplemental Data, Table S1). Homology rates ranged from
65.25% (Choristoneura fumiferana vs Chironomus tentans) to
99.68% (Lucilia cuprina vs Calliphora erythrocephala). Thus it
may be presumed with confidence that the binding domain of
the receptor shares sufficient conservation across the sample
of species to ensure that variability in receptiveness to
ligands was minimal throughout. As expected, a reduced
degree of sequence similarity was evident between insects
and noninsects. Nevertheless, the extent of homology—
encompassing values from 59.56% (A. silvatica vs Aedes
aegypti) to 51.3% (C. sapidus vs C. tentans)—remained far
above the calculated thresholds. Complete SeqAPASS re-
ports, incorporating data related to all relevant species, may
be found in the Supplemental Data, Table S4.
Construction of workflows
Derivation of structural alerts and accompanying phys-
icochemical property ranges. Structural alerts, formulated
and coded according to the protocols described previously in
Identification and construction of key structural features and
alerts, are described below and depicted in Table 3. Figure 3
shows representatives of the major classes of active binder
recovered, from which the basis of the rule‐sets was derived.
Because of evidence indicating a potential for occupation of
overlapping, yet distinct, sites on the receptor‐binding domain,
unique rules were developed accounting for both steroidal and
nonsteroidal subtypes (Billas et al. 2003; Evenseth et al. 2019).
Alerts were accompanied, where appropriate, by relevant
physicochemical property ranges (calculated in KNIME ac-
cording to protocols described previously in the section
Calculation of molecular physicochemical descriptors), further
refining the chemical space. These are displayed in Table 4.
Types of rule‐sets: Steroidal. Compounds holding the
characteristic tetracyclic core, complete with the presence of
the C3 oxygen moiety and C17 branched carbon side chain
(represented by turkesterone; Figure 3A), meet the primary
criterion for inclusion in the steroidal rule‐sets. These mole-
cules embed within an L‐shaped binding cleft, with the con-
servation of the tetracyclic hydrocarbon structure essential in
the mediation of hydrophobic interactions anchoring mole-
cules in a favorable position (Billas and Moras 2005). Omis-
sion of the C17 chain, positioned deepest within the pocket,
eliminates the various van der Waals interactions that further
assist in ligand–receptor complex stabilization. The require-
ment that the side chain occupy sufficient volume to facilitate
these interactions is represented through incorporation of
the atomic and bond contribution of van der Waals volume
(VABC) volume descriptor—a minimum threshold of which
must be met for “active” status to be returned. This scaffold
further functions as a frame supporting the numerous polar
groups engaging in hydrogen bonding with flanking amino
acid residues—among which are the C2, C3, and C20
hydroxyls and the C6 and C14 carbonyl moieties (Billas and
Moras 2005; Evenseth et al. 2019). Although it is the C3
hydroxyl that is apparently most essential in distinguishing
active binders (hence its integration into the structural alert),
the distribution of the further hydrogen‐bond participants
about the molecule is more flexible. Thus the requirement for
these groups is represented through inclusion of a phys-
icochemical parameter specifying the necessity for the sum of
hydrogen‐bond donors and acceptors as greater than, or
equal to, 4.
Types of rule‐sets: Nonsteroidal. Nonsteroidal entries must
match (within the molecular initiating event pathway) repre-
sentations of one of 3 defining scaffolds: either diacylhydrazine
(e.g., tebufenozide; Figure 3B), methylene‐γ‐lactam (represented
by Figure 3C), or substituted tetrahydroquinoline (represented by
TABLE 2: Interspecies sequence similarity of ecdysone receptor ligand binding domains (expressed as percentage), as determined through
SeqAPASSa
aNoninsect species and their homology scores are in italics. Insect species and their homology scores are in bold. Coloration provides visual representation of extent of
homology. For genus names, see Table 1.
bAlternatively known as Calliphora vicina.
cSequence predicted.
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Figure 3D). The binding site occupied by these molecules, al-
though sharing a region of overlap with that of the steroids, is
nevertheless distinct—possessing a pronounced V shape (Billas
and Moras 2005; Evenseth et al. 2019). General to all classes is an
upper molecular weight limit of 500, reflecting the compact,
drug‐like form of the studied compounds. The diacylhydrazine
alert stipulates the inclusion of an acyl benzene unit—the ring
occupying a position between adjacent methionine residues and
the carbonyl acting as a hydrogen‐bond acceptor (Billas and
Moras 2005). A second carbonyl, serving a similar function, is
separated from this courtesy of a linking unit consisting of 2 atoms
limited to combinations of carbon or nitrogen, the latter of which
is generally present in the form of a secondary amine free to
participate in hydrogen‐bond donation. A minimum degree of
steric bulk, in the form, for example, of substitution at the aryl
moiety, appears necessary to ensure that essential hydrophobic
interactions are maintained. Thus a lower molecular weight bound
of 290 is present solely in this group.
The methylene‐γ‐lactam unit is rendered as a 5‐membered
ring (atom identity unspecified) substituted with 3 essential units:
the carbonyl, the methylene, and also a secondary cyclic unit.
Although the former is unambiguously a hydrogen‐bond acceptor,
the latter 2 are implicated in hydrophobic interactions (Dinan
et al. 2012). Because evidence suggests that the structure of the
additional ring may vary with respect to size and composition, the
alert is coded with generality in mind (Birru et al. 2010). A flexible
unit linking the 2 cyclic fragments is common to all in this
category—a factor represented by the requirement for the pres-
ence of at least one rotatable bond. Comparatively little is known
about the binding mode of the less characterized tetrahy-
droquinoline class (Dinan et al. 2012; Giacoppo et al. 2017).
Accordingly, it proved necessary to represent the structure as
merely its core component—the 1,4‐substituted, 10‐membered
fused ring, with atom identity and bond nature undefined.
Excessive substituent bulk appears to be detrimental to activity,
and thus a maximum VABC threshold is stipulated.
Integration into a sequential KNIME workflow. A combi-
nation of structural and physicochemical rule‐sets was achieved
within the framework of KNIME workflows, which are openly
available for download (figshare 2020). Figure 4 outlines the
general structure of the workflows, both for the molecular ini-
tiating event level and for the adverse outcome level, charting
the passage of compounds (encoded as SMILES strings)
through appropriate selection filters to final classification as
either active or inactive.
Structures should be uploaded in the form of a .csv file
composed of 3 columns, each with a header, one containing
SMILES strings (headered “SMILES”), one a numerical identifier
(“ID”), and one a compound name (“Name”). A sample entry
file may be found, for illustrative and testing purposes, in the
Supplemental Data, Table S5.
Assessment and validation of workflow
performance
Internal validation. To assess the capacity of the workflows to
successfully predict the status of known active and inactive
TABLE 3: Visual representation of essential structural features, accompanied by SMILES arbitrary target specification (SMARTS) strings, as implemented
within Konstanz Information Miner (KNIME) workflowsa







Nonsteroidal Diacylhydrazine c1ccccc1~[#6;!R](~O)~[#6,#7]~[#6,#7]~[#6;!R](~O)~[#6] YES YES
Methylene‐γ‐lactam *(~[C;!R])~1~*~*~*(=O)~[*;R1]~1~*~*~[*;R] YES NO
Tetrahydro‐quinoline *~1~*~*(~*[*;R])~*~2~*~*~*~*~*~2~*~1~[*;!R][*;R] YES NO
aYES/NO means the presence or not of alerts within molecular initiating event (MIE) and adverse outcome (AO) screens.
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compounds, screening was performed on the complete in-
ventory of 555 sourced chemicals. Outcomes are shown in
Table 5, with performance metrics determined for both molec-
ular initiating event– and adverse outcome–level rule‐sets. The
capacity to appropriately predict compounds as active binders
was uniformly high, with a minimum success rate of 94.5% (rep-
resenting 53 correctly assigned from the 55 adverse outcome
steroidal entries). Each excluded steroid lacked the stipulated
3‐OH unit (Supplemental Data, Table S2: IDs 45, 47, 80, 95, and
195) whereas the single unmatched nonsteroidal compound
appeared as a methylene‐γ‐lactam with an uncommon fused ring
unit (ID 320).
Because of a general structural similarity between the
active and nonactive compounds, a definitive exclusion of
the latter was challenging. Across both molecular initiating
event and adverse outcome cohorts, between 21.6% of the
44.1% of those compounds displaying inactivity at the re-
ceptor were, through screening, correctly excluded. Among
steroidal entries, numerous inactives were correctly identi-
fied on account of their generally smaller VABC and reduced
quantity of hydrogen‐bonding participants. With regard to
nonsteroidals, both tetrahydroquinoline and diacylhydrazine
FIGURE 3: Structures of compounds representing major binder classes steroidal (A), diacylhydrazine (B), methylene‐γ‐lactam (C), and
tetrahydroquinoline (D).
TABLE 4: Physicochemical property ranges accompanying essential
structural features included within workflows
Screen Fragment Descriptor Rule
Steroidal H‐bonding participants ≥4
VABC ≥436
Nonsteroidal All classes Molecular weight ≤500
Diacylhydrazine Molecular weight ≥290
Methylene‐γ‐lactam Rotatable bonds ≥1
Tetrahydroquinoline VABC ≤410
VABC= atomic and bond contribution of van der Waals volume.
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classes were more reliably differentiated than were the
methylene‐γ‐lactams.
Screening of external compound inventory. To inves-
tigate the performance of the rule‐sets against a more general
selection of chemicals, an inventory was screened of 8795
compounds sourced through the USEPA ToxCast initiative (in-
corporating a variety of pharmaceuticals, food additives, cos-
metic ingredients, and synthetic precursors: listed in the
Supplemental Data, Table S6; Richard et al. 2016). A list of
matches is shown in the Supplemental Data, Table S7. Through
the molecular initiating event–level screen, a collection of
34 potentially active binders was identified, 29 nonsteroidal in
structure and 5 steroidal. Of this number, 16 were captured by
adverse outcome rules.
Aside from a selection of pesticides—including the
diacylhydrazines halofenozide, methoxyfenozide, and
tebufenozide as present in the training set—the predicted
binders are dominated by pharmaceuticals. Notably repre-
sented are several members belonging to the pyrazolone
class of nonsteroidal anti‐inflammatory drugs, including
aminopyrine (Figure 5A), phenazone, and propyphenazone,
each of which shares structural similarity with the methylene‐
γ‐lactam core. This motif is further present as a fragment
within the larger compounds including doxapam, el-
trombopag, and a small number of azo dyes. Alongside the
aforementioned pesticides, the diacylhydrazine alert was
matched with members of the amphenicol antibiotic family,
chloramphenicol (Figure 5B), florfenicol, and thiamphenicol.
Vatalanib (Figure 5C), an inhibitor of the vascular endothelial
FIGURE 4: Integration of structural and physicochemical rule‐sets in construction of molecular initiating event (MIE)–level and adverse
outcome–level Konstanz Information Miner (KNIME) workflows. VABC= atomic and bond contribution of van der Waals volume; AO= adverse
outcome.
TABLE 5: Outcomes of internal validation exercise, describing the performance of both molecular initiating event (MIE) and adverse outcome (AO)
workflows against appropriate training setsa
Active Inactive
Screen Matched Total % Matched Matched Total % Matched
MIE Steroidal 158 160 98.8 10 14 71.4
Nonsteroidal 273 274 99.6 29 37 78.4
AO Steroidal 52 55 94.5 19 34 55.9
Nonsteroidal 4 4 100.0 — — —
aInclusion rates for known active and inactive compounds.
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growth factor receptor, was the sole recovered bearer of the
tetrahydroquinoline moiety.
DISCUSSION
The present study accumulated existing data concerning the
identity of known EcR binders, allowing delineation of shared
structural and physicochemical characteristics. The data were
adapted into a series of rules for implementation into a KNIME
workflow, enabling detection of compounds likely to interfere
with ecdysone signaling. It is intended that AOP‐anchored, in
silico techniques will, in time, support strategies for an in-
tegrated approach on testing and assessment (Tollefsen
et al. 2014). Examination of literature sources produced an in-
ventory composed of 555 distinct compounds (across 10 insect
species) for which a capacity to act at the EcR had been ex-
perimentally assessed. Drawing from assay activity data, it was
judged that a great majority of these compounds—470 in all—
displayed potencies sufficient to indicate specific activity at the
receptor, whereas only a comparatively small minority (the re-
maining 85) did not. Subdivision of these sets, both by the
nature of available data with respect to adverse outcome
pathway level and by key structural motif, led to the creation of
the characteristic strands: molecular initiating event and ad-
verse outcome, steroidal and nonsteroidal. The latter was ne-
cessitated by the apparent part‐distinction of the site on the
EcR ligand‐binding domain occupied by each respective class
(Billas et al. 2003).
Our approach was by necessity dictated through data
availability, with a focus placed on one particularly prevalent
class among the arthropod phylum—insects. Expansion of the
taxonomic breadth of applicability to encompass other major
species classes would of course be beneficial to the utility of
the model as a tool in an environmental risk assessment setting.
Analysis by SeqAPASS indicated high conservation of ligand‐
binding domain sequence homology across the 10 insect
species (6 Dipteran and 4 Lepidopteran) from which the data
were drawn (LaLone et al. 2016). Importantly, this extended
(with a minor reduction) to representative species sourced from
alternative subphyla, such as crustaceans, myriapods, and
arachnids. Such findings stand in support of evidence drawn
from alternative studies, which suggest that EcR sequence
homology conforms to a respectable degree across even
substantially divergent species, albeit with minor amino acid
variation at key positions holding association with variable
sensitivity toward specific nonsteroidal pesticides (Nakagawa
and Henrich 2009; Song et al. 2017b; Evenseth et al. 2019).
Although experimental evidence from noninsect classes is
scarce, a limited number of studies have reported the devel-
opment of systems that may allow future widespread screening
of EcR binding capacity in selected crustacean species, and
hence providing routes through which these hypotheses might
be tested (Yokota et al. 2011; De Wilde et al. 2013; Asada
et al. 2014; Chan et al. 2019).
An example of an instance in which extension of domain
may prove particularly useful is the impact of ecdysone sig-
naling disruption on life‐cycle progression in the crustacean
Daphnia magna. Reproductive toxicity in this species, which
forms the subject of Organisation for Economic Co‐operation
and Development (2012) test guideline 211, may be mediated
through perturbations in the process of ecdysis (Rodriguez
et al. 2007). Furthermore, EcR antagonism has been implicated
in ecdysis‐associated mortality, as described in an arthropod‐
specific AOP “Ecdysone receptor agonism leading to in-
complete ecdysis associated mortality,” which has recently
FIGURE 5: Structures of aminopyrine (A), chloramphenicol (B), and vatalanib (C).
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been interrogated in detail in various in silico, in vitro, and in
vivo assays (Fay et al. 2017; Song et al. 2017a, 2017b; Song
and Tollefsen 2018).
It should be noted that the breadth of structural and
physicochemical space present in the training set will of
course dictate the specificity or generality of the alerts derived
from it. The studies from which these data were drawn tended
to display a focus on examining the influence on activity of
small deviations about a central framework, be it the steroid,
diacylhydrazine, methylene‐γ‐lactam, or tetrahydroquinoline
cores. Thus the scope of domain is necessarily limited to
derivations of each of these units, with extrapolation beyond
informed by interpretation of key ligand‐binding site inter-
actions. Internal validation revealed that 68% of experimental
nonactives were predicted to be active. Although this might
appear somewhat conservative, it is important to reiterate that
a distinction between features definitively separating appa-
rent active and inactive compounds was not necessarily
readily apparent, given the extent of the structural similarity
evident between them. Through detection of probable
binders, the workflows may find utility in the guidance of
future programs focused on experimental testing of chemicals
liable to function as endocrine disruptors. After screening of a
representative nonselective external compound inventory, it
was revealed that approximately 0.4% of the 8795 entries
were flagged as potentially active at the molecular initiating
event level. With more extensive collections, such a pro-
portion could represent identification of hundreds of chem-
icals in general use.
With regard to ligand structure, general diversity among
the active steroids was limited. Conservation of the C20, C21,
and C22 branch proved an absolute requirement, with com-
pounds lacking such a motif, including the acknowledged
ecdysteroid metabolites rubrosterone (Figure 6A) and post-
sterone (Figure 6B), notable for their inactivity (Dinan 2003). It
is, therefore, a feature of this screen that vertebrate steroid
families—such as sex hormones (e.g., estradiol; Figure 6C),
corticosteroids (e.g., corticosterone; Figure 6D), and the
FIGURE 6: Structures of rubrosterone (A), poststerone (B), and compounds representing predicted classes of nonbinding natural products including
estradiol (C), corticosterone (D), zeorin (E), brassinolide (F), and ouabain (G), alongside a selection of in vitro ecdysone receptor antagonists,
cucurbitacin B (H), isomitraphylline (I), and suffruticosol A (J).
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synthetic derivatives of each—would be predicted to be
nonactive. Further excluded are the prokaryotic hopanoids
(e.g., zeorin; Figure 6E), alongside the phytosteroidal
brassinolide (Figure 6F) and cardiac glycoside (e.g., ouabain;
Figure 6G) products. Accordingly, no data could be recovered
attesting to the ability of any of these classes to bind the EcR.
Many steroidal ecdysteroids described in the literature have
their origins in selected plant species, in which they are
speculated to play a role in defence against herbivore grazing
(Dinan 2001).
Whereas the diacylhydrazine backbone is held in common,
the methylene‐γ‐lactam and tetrahydroquinoline motifs are
absent entirely from the adverse outcome–level rule‐set. Such
inequalities can be accounted for through consideration of the
aims of the original studies, with the great majority of non-
steroidal compounds derived from research directed at the
construction of novel EcR agonists through rational design. The
primary interest of these studies was to assess direct binding
affinity (i.e., the molecular initiating event), as opposed to as-
sessing downstream effects that may arise within the organism
(i.e., the key events and adverse outcomes). It has been es-
tablished that the diacylhydrazines, including tebufenozide and
methoxyfenozide, commercial insecticides, function through
this route (Carlson et al. 2001). The activities of tetrahy-
droquinolines and methylene‐γ‐lactams have been demon-
strated in various in vitro assays and, despite displaying
promising performance at this level, further development to-
ward their commercial adoption has yet to be pursued.
Although less intensively examined, evidence suggesting
EcR antagonist capacity has emerged in a limited number of
compounds. Twenty‐six active chemicals were recovered from
the literature—ultimately too few for derivation of reliable
alerts given the structural diversity present (Supplemental Data,
Table S8; Dinan et al. 1996, 1997, 2001a, 2001b). Prominent in
this set were phytosteroids of the cucurbitacin and withanolide
families (represented by cucurbitacin B; Figure 6H). Similarities
between these compounds and the endogenous ecdysteroids
are readily apparent, the primary variation being in side
chain substitution. A trio of mitraphylline‐like oxindole alkaloids
was further present (isomitraphylline; Figure 6I), as were
2 benzodioxole derivatives and 6 stilbenoids (represented by
suffruticosol A; Figure 6J).
CONCLUSIONS
Key structural and physicochemical characteristics of more
than 500 experimentally determined compounds have been
discerned, to form rule‐sets expressed as workflows within
KNIME, enabling identification of compounds likely to exert
activity through the EcR within arthropods, and within insects in
particular. Homology analysis by SeqAPASS revealed high
levels of sequence conservation in the EcR ligand binding
domains present in these species, indicating that reliable ex-
trapolation is possible. A consideration of the assay systems
employed in generation of the data allowed distinctions be-
tween molecular initiating event–level (receptor activation) and
adverse outcome–level (gross organism) effect. An ability to
correctly identify binders was demonstrated at both levels,
while screening of an external chemical inventory allowed fur-
ther identification of compounds exhibiting a potential to in-
fluence signaling through the receptor. Combined, these data
incorporate the bulk of publicly accessible knowledge con-
cerning structure–activity relationships at the EcR. It is intended
that their utility in rapidly and accurately identifying potential
endocrine‐disrupting substances might reduce uncertainty in
environmental risk assessment.
Supplemental Data—The Supplemental Data are available on
the Wiley Online Library at https://doi.org/10.1002/etc.4733.
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